SecurityEYEG / Eyegate Pharmaceuticals Inc. (30233M107)
President and CEOFROM STEPHEN
Institutional Owners23
Form N-Q Owners2
Institutional Shares4,159,659 - 24.18% (ex. N-Q)
Weighted Average Number Of Share Outstanding Basic And Diluted17,204,778 shares (as of 2017-09-30) (ex. N-Q)
Institutional Value$ 560,000 USD (ex. N-Q)
Related EYEGW / Eyegate Pharmaceuticals Inc. Warrants

Institutional Stock Ownership and Shareholders

Eyegate Pharmaceuticals Inc. (NASDAQ:EYEG) has 23 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,159,659 shares. Largest shareholders include Empery Asset Management, LP, Armistice Capital, Llc, Ipsa (innoven Partenaires S.a.), Vanguard Group Inc, Virtu Financial LLC, Citadel Advisors Llc, Two Sigma Securities, Llc, Macquarie Group Ltd, IFP Advisors, Inc, and Wedbush Securities Inc.

Eyegate Pharmaceuticals Inc. (NASDAQ:EYEG) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2018-02-14 13F-HR CREDIT SUISSE AG/ 30,000 20,000 -33.33 35 21 -40.00
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2018-01-24 13F-HR Vantage Investment Advisors, LLC 6,500 6,500 0.00 8 7 -12.50
2018-01-24 13F-HR IFP Advisors, Inc 25,800 23,800 -7.75 30 25 -16.67
2018-02-14 13F-HR VANGUARD GROUP INC 268,119 268,119 0.00 314 287 -8.60
2018-02-09 13F-HR BlackRock Inc. 635 635 0.00 1 1 0.00
2018-02-14 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 304 304 0.00 0 0
2018-01-17 SC 13D/A IPSA (INNOVEN PARTENAIRES S.A.) 1,045,279 770,065 -26.33
2018-02-14 13F-HR MACQUARIE GROUP LTD 25,400 27
2018-02-14 SC 13G/A ARMISTICE CAPITAL, LLC 1,614,000 1,284,000 -20.45
2018-02-15 13F-HR/A-1 Sabby Management, LLC 46,378 0 -100.00 54 0 -100.00
2018-02-14 13F-HR TWO SIGMA SECURITIES, LLC 32,022 30,483 -4.81 37 33 -10.81
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 524 0 -100.00 1 0 -100.00
2018-01-03 13F-HR Washington Trust Bank 1,700 2
2018-02-09 13F-HR WEDBUSH SECURITIES INC 20,000 21
2017-11-14 13F-HR DEUTSCHE BANK AG\ 200 0 -100.00 0 0
2018-02-14 13F-HR MORGAN STANLEY 740 740 0.00 1 1 0.00
2017-11-29 N-Q Vanguard Index Funds (see advisory)
2018-02-14 13F-HR ROYAL BANK OF CANADA 1 1 0.00 0 0
2018-02-14 13F-HR NORTHERN TRUST CORP 11,277 14,553 29.05 13 16 23.08
2017-10-17 13F-HR Creative Planning 300 0 -100.00 0 0
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 100 600 500.00 0 1
2018-02-09 13F-HR Holistic Financial Partners 1,900 2
2018-01-16 SC 13G/A Empery Asset Management, LP 1,500,000 1,582,380 5.49
2018-02-09 13F-HR Virtu Financial LLC 15,967 71,910 350.37 19 77 305.26
2018-02-14 13F-HR UBS Group AG 0 4,400 0 5
2018-02-09 13F-HR CITADEL ADVISORS LLC 32,169 34

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( EYEG / Eyegate Pharmaceuticals Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

CUSIP: 30233M107